Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer
Clinical trial NCT02948543 · UNKNOWN
Trial details
- NCT number
- NCT02948543
- Sponsor
- University of Sydney
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2024-12-01
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.